| Patents for C07D 223 - Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom (8,732) |
|---|
| 05/26/2005 | US20050113363 Hydroxyalkanoylaminolactams and related structures as inhibitors of A beta protein production |
| 05/25/2005 | EP1533298A1 3-aminopyrrolidone derivatives |
| 05/25/2005 | EP1531879A1 Use of organic compounds |
| 05/25/2005 | EP1286673B1 Ligands of integrin receptors |
| 05/25/2005 | DE10349669B3 Bengamide-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung Bengamide derivatives, to processes for their preparation and their use |
| 05/24/2005 | US6897323 Highly enantiomerically pure lactam-substituted propanoic acid derivatives and methods of making and using same |
| 05/24/2005 | US6896772 Method for separating ammonia from solutions containing caprolactam and ammonia |
| 05/19/2005 | WO2005044803A1 Bengamide derivatives, method for the production thereof and use thereof for the treatment of cancer |
| 05/19/2005 | US20050107444 E.g., 2-(3-{3-[(2-chloro-3-(trifluoromethyl)-benzyl)-(2,2-diphenylethyl)-amino]-propoxy}phenyl)-1-morpholin-4-yl-ethanone; agonists of the nuclear receptors, LXR alpha and LXR beta used to increase ABCA1, ABCG1, and apolipoprotein E expression and inhibiting cholesterol absorption |
| 05/19/2005 | US20050107360 Bicyclic compounds |
| 05/19/2005 | US20050107359 Crystalline polymorphic and amorphous forms of benazepril hydrochloride |
| 05/19/2005 | US20050106238 Orodispersible pharmaceutical composition comprising ivabradine |
| 05/19/2005 | CA2543003A1 Bengamide derivatives, method for the production thereof and use thereof for the treatment of cancer |
| 05/18/2005 | CN1617883A Solid salts of benzazepine compounds and pharmaceutical compositions containing them |
| 05/18/2005 | CN1616433A Carbamazepine medicine and its preparing method |
| 05/18/2005 | CN1616432A Compound, its use and pharmaceutical compositions comprising same |
| 05/12/2005 | WO2005042697A2 Compounds, compositions and methods |
| 05/12/2005 | WO2005042491A1 Benzazepine derivatives and methods of prophylaxis or treatment of 5ht2c receptor associated diseases |
| 05/12/2005 | WO2005042490A1 Benzazepine derivatives and methods of prophylaxis or treatment of 5ht2c receptor associated diseases |
| 05/12/2005 | WO2005042489A1 N-substituted benzene sulfonamides |
| 05/12/2005 | US20050101600 4-Hydroxy-1-toluenesulfonyl-2,3,4,5-tetrahydro-1H-1-benzazepine, for example; useful as the preventive and/or treatment medicine against diseases caused by stress |
| 05/12/2005 | CA2544350A1 N-substituted benzene sulfonamides |
| 05/11/2005 | EP1528927A1 Use of carboxamides for the treatment of tinnitus |
| 05/11/2005 | EP1528921A2 Methods for treatment and prevention of gastrointestinal conditions |
| 05/11/2005 | EP1154777B1 Medicament for treating hypertension |
| 05/11/2005 | CN1615298A Method for preparing lactam |
| 05/10/2005 | US6890927 Tartrate salts of 5,8, 14-triazateracyclo[10.3.1.02,11 04.9]-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof |
| 05/10/2005 | US6890921 Selectively inhibit binding to alpha-1a adrenergic receptor; 1-(2-phthalimidoethyl)-4-(2-isopropyloxyphenyl)piperazine; N-(Ethyl-2-(2-iso-propyloxyphenyl)piperazin-4-yl))-(1'-(2-oxy -piperdinyl))acetamidemide |
| 05/10/2005 | US6890920 Therapeutic treatment of asthma, chronic obstructive pulmonary disease, rhinorrhea due to the common cold, rhinitis |
| 05/06/2005 | WO2005040126A1 Substituted dibenzo-azepine and benzo-diazepine derivatives useful as gamma-secretase inhibitors |
| 05/06/2005 | WO2005040108A1 Prolinamide derivatives as sodium and/or calcium channel blockers or selective mao-b inhibitors |
| 05/06/2005 | WO2005039591A1 Benzazepine derivatives as mao-b inhibitors |
| 05/06/2005 | CA2543287A1 Benzazepine derivatives as mao-b inhibitors |
| 05/04/2005 | EP1411881B1 5ht2c receptor modulators |
| 05/04/2005 | CN1612887A Phosphino-aminophosphines |
| 05/04/2005 | CN1199945C Method for producing cyclic lactams |
| 05/03/2005 | US6887864 Anticancer agents, a benzoylamino-azepan-3-yl-isonicotinamide compounds |
| 05/03/2005 | US6887838 Bleach boosting components, compositions and laundry methods |
| 05/03/2005 | US6887352 Recovering 1,6-hexanediamine from mixtures including 6-amino-hexanenitrile, 3,4,5,6-tetrahydro-2H-azepine and adiponitrile, using chromatography, while preventing by-products by process control |
| 04/28/2005 | WO2005037796A1 Compounds and methods for treating dyslipidemia |
| 04/28/2005 | WO2005037795A2 Substituted spirobenzazepines |
| 04/28/2005 | WO2005037785A2 Derivatives of n-[phenyl(pyrrolidine-2-yl)methyl]benzamide and n-[(azepan-2-yl)phenylmethyl]benzamide, preparation method thereof and application of same in therapeutics |
| 04/28/2005 | WO2005037269A1 Novel piperidine derivative |
| 04/28/2005 | WO2005007630A3 Aryl fused azapolycyclic compounds |
| 04/28/2005 | WO2004093817A3 Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 04/28/2005 | US20050090494 Such as N-[2-(3-{[1-(3,4-dichlorobenzylpiperidinyl]aminohydroxypropoxy)phenyl]acetamide; antiinflammatory agents, antiarthritic agents; chronic obstructive pulmonary disease, asthma, multiple sclerosis |
| 04/28/2005 | US20050090485 7-Arylsulfonamido-2,3,4,5-tetrahydro-1h-benzo'diazepine derivatives with 5ht6 receptor affinity for the reatment of cns disorders |
| 04/28/2005 | CA2542727A1 Derivatives of n-[phenyl(pyrrolidine-2-yl)methyl]benzamide and n-[(azepan-2-yl)phenylmethyl]benzamide, preparation method thereof and application of same in therapeutics |
| 04/27/2005 | EP1525189A1 Crystalline polymorphic and amorphous forms of benazepril hydrochloride |
| 04/27/2005 | CN1610666A Benzamidine derivative |
| 04/27/2005 | CN1198619C Application of benzoaza-N-acetic acid derivative in preparation of medicine for treating pulmonary hypertension |
| 04/21/2005 | WO2005035504A2 5-h -benzo [d] naphth [2, 1-b] azepine derivative as selective d1/d5 receptor antagonists for the treatment of obesity and cns disorders |
| 04/21/2005 | US20050085520 amidation and/or dehalogenation to form substituted [4-carbamoyl-2-hydroxypentyl]-benzamides; potent enzyme inhibitors of Asp2 [B-secretase, BACE1 (b-site Alzheimer's amyloid precursor protein cleaving enzyme) or Memapsin]; Alzheimer's disease |
| 04/21/2005 | US20050085461 Benzenesulfonamide derivatives |
| 04/21/2005 | US20050085460 useful as therapeutics in treatment of cancers and the amelioration of the effects of stroke, head trauma, and neurodegenerative disease |
| 04/21/2005 | CA2526017A1 5-h-benzo[d]naphth[2,1-b]azepine derivative as selective d1/d5 receptor antagonists for the treatment of obesity and cns disorders |
| 04/20/2005 | EP1524265A1 Prolinamide derivatives as sodium and/or calcium channel blockers or selective MAO-B inhibitors |
| 04/14/2005 | US20050080119 Diaminopropionic acid derivatives |
| 04/14/2005 | US20050079541 Immunoadhesin comprising a glycorprotein v1 domain |
| 04/13/2005 | CN1196684C Process for producing N.N'-carbonyl dilactan |
| 04/12/2005 | US6878822 Ethylene derivative having a nitrogen-containing 7-membered ring |
| 04/07/2005 | WO2005030794A2 Hemiasterlin derivatives and uses thereof |
| 04/07/2005 | WO2005030730A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE α-AMINO-ϵ-CAPROLACTAM OR SALT THEREOF AND INTERMEDIATE FOR THE PRODUCTION |
| 04/07/2005 | US20050075332 Tricyclic compounds with antiviral activity |
| 04/07/2005 | US20050075327 Carbamic acid alkyl ester derivatives |
| 04/07/2005 | US20050075325 Selective D1/D5 receptor antagonists for the treatment of obesity and CNS disorders |
| 04/07/2005 | CA2539823A1 Hemiasterlin derivatives and uses thereof |
| 04/06/2005 | EP1519915A2 Tricyclic steroid hormone nuclear receptor modulators |
| 04/05/2005 | US6875866 Process for synthesis of D1 receptor antagonists |
| 03/31/2005 | US20050070520 Aza-cyclic compounds as modulators of acetylcholine receptors |
| 03/30/2005 | CN1600779A Method for transforming to epsi-caprolactam O-alkyl-epsi-caprolactim |
| 03/30/2005 | CN1600428A Method for preparing catalyst of containing MFI structured molecular sieve |
| 03/30/2005 | CN1194965C Method for producing cyclic lactams |
| 03/24/2005 | WO2004080932A3 Distillative method for separating hexamethylenediamine from a mixture comprising hexamethylenediamine, -aminocapronitrile and tetrahydroazepine |
| 03/24/2005 | US20050065162 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues |
| 03/23/2005 | EP1515726A1 Morpholine and tetrahydropyran derivatives and their use as cathepsin inhibitors |
| 03/23/2005 | CN1599607A Carbinols for the treatment of neuropathic dysfunction |
| 03/23/2005 | CN1193788C Beta 2-adrenergic receptor agonist |
| 03/22/2005 | CA2095970C Novel high-temperature dehydrogenation process |
| 03/17/2005 | WO2005023772A1 Malonamide derivatives blocking the activity of gama-secretase |
| 03/17/2005 | WO2005009972A3 Process for preparation of benazepril |
| 03/17/2005 | US20050059702 Elevate the progenitor and/or stem cell population in peripheral blood or bone marrow; treatment of HIV, inflammatory condition like rheumatoid arthritis, tumor, asthma; 4-(3,3''-Dimethyl-3',4',5',6'-tetrahydro-2'H-cis-[2,2';6',2'']terpyridin-1'-yl-butylamine |
| 03/17/2005 | US20050059699 N-acylated lipophilic amino acid derivatives |
| 03/16/2005 | EP1513825A2 Anti tubercular drug: compositions and methods |
| 03/16/2005 | EP1513816A2 Method of preparing a 5h-dibenz(b,f)azepine-5-carboxamide |
| 03/16/2005 | EP1355894B1 Amidinophenylalanine derivatives as thrombin inhibitors |
| 03/16/2005 | CN2685337Y Apparatus for concentrating hexanolactam hydrosolution |
| 03/16/2005 | CN1596245A Process for recovering caprolactam |
| 03/10/2005 | WO2005021487A1 Cathepsin inhibitors |
| 03/10/2005 | WO2004096795A3 C-fms kinase inhibitors |
| 03/10/2005 | US20050054683 Microbiocides; bacteriocides; oxazolidinone compound |
| 03/10/2005 | US20050054633 Malonamide derivatives |
| 03/10/2005 | CA2535366A1 Cathepsin inhibitors |
| 03/09/2005 | EP1512684A1 use of derivative of para-phenylenediamine substituted by a homopiperidine ring, for the dyeing of keratinous fibres |
| 03/09/2005 | EP1511770A2 Immunoadhesin comprising a glycoprotein vi domain |
| 03/09/2005 | EP1511727A2 Aromatic sulfones and their medical use |
| 03/09/2005 | EP1511480A2 Inhibitors of glycoprotein vi |
| 03/08/2005 | US6864372 Process for the production of sulfonic esters |
| 03/08/2005 | US6864250 N-acylated lipophilic amino acid derivatives |
| 03/03/2005 | WO2005019180A1 6-(2,2,2-TRIFLUOROETHYLAMINO)-7-CHLORO-2,3,4,5-TETRAHYDRO-1H-BENZO[d]AZEPINE AS A 5-HT2c RECEPTOR AGONIST |